Grupo 1: Oncología Interdisciplinar y Biotecnológica
Código de grupo: 6.01
Tipo de grupo: Consolidado
Descripción del grupo: Oncología interdisciplinar y biotecnológica
Jefe de Grupo: Dra. Ana Álvarez González y Dra. Mercedes Muñoz Fernández
| Integrantes del grupo | |
|---|---|
| Investigadores y personal de apoyo |
| ALONSO | FARTO | JUAN CARLOS | Recognised Researcher |
| ÁLVAREZ | GONZÁLEZ | ANA | First Stage Researcher |
| ÁLVAREZ | FERNÁNDEZ | EMILIO | |
| AYALA | LÁZARO | RAFAEL | First Stage Researcher |
| BLANCO | RODRÍGUEZ | JOSÉ | First Stage Researcher |
| CALÍN | LORCA | ANA | First Stage Researcher |
| CALVO | MANUEL | FELIPE ÁNGEL | Established Researcher |
| CASCON | PEREZ-TEIJON | MARIA ELENA | |
| CUERVO | DEHESA | MIGUEL ANGEL | First Stage Researcher |
| DE INGUNZA | BARON | LOURDES | |
| DEL VALLE | HERNÁNDEZ | EMILIO | First Stage Researcher |
| GARCÍA | HERNÁNDEZ | MARÍA JESÚS | First Stage Researcher |
| GARCÍA | LEAL | ROBERTO | |
| GÓMEZ | ESPÍ | MARINA | Recognised Researcher |
| GÓMEZ | CORES | SUSANA | First Stage Researcher |
| GONZÁLEZ | SAN SEGUNDO | CARMEN | Recognised Researcher |
| LÓPEZ | BOTE | MIGUEL ÁNGEL | First Stage Researcher |
| LOZANO | BARRIUSO | MIGUEL ANGEL | First Stage Researcher |
| MEDIAVILLA | SANTOS | LYDIA | |
| MORENO | DOMENE | MERCEDES | First Stage Researcher |
| MUÑOZ | FERNANDEZ | MERCEDES | |
| NAVARRO | CUELLAR | CARLOS | Recognised Researcher |
| OCHANDIANO | CAICOYA | SANTIAGO | |
| ORCAJO | RINCÓN | JAVIER | |
| PELIGROS | GÓMEZ | MARÍA ISABEL | Recognised Researcher |
| PRIETO | RODRIGUEZ | MARIA JESUS | |
| RAMON | BOTELLA | ENRIQUE | |
| RODRÍGUEZ | MARTÍN | MARCOS | First Stage Researcher |
| ROTGER | REGÍ | AMANDA | |
| RUIZ | GALAN | GEMA | |
| SALMERON | ESCOBAR | JOSE IGNACIO | Recognised Researcher |
| SERRANO | ANDREU | FRANCISCO JAVIER | Recognised Researcher |
| SIERRA | DÍAZ | FERNANDO | First Stage Researcher |
| SOLE | PESUTIC | CLAUDIO VICENTE | Recognised Researcher |
| TOUSIDONIS | RIAL | MANUEL ALEJANDRO |
| Líneas de Investigación | |||
|---|---|---|---|
| Axis 1: High-precision radiotherapy (intraoperative radiotherapy)
L1: Stereotactic surgical navigation. L2: In vivo dosimetry guided by 3D printing. L3: Mobile miniature linear accelerator: pre-robotization and automation. Axis 2: Biological response in oncology L1: Post-radiochemotherapy response. L2: Biological dosimetry: chromosomal liquid biopsy. L3: Post-neoadjuvant radioresistance and radiosensitivity. L4: Oncologic bioimaging and response. Axis 3: Oligocancer L1: Radiosurgical rescue. L2: Staging by functional imaging. L3: Proton therapy: clinical models. |
|||
| First decile publications | 5 | 147,8 |
| First quartile publications | 9 | 167,0 |
| Second quartile publications | 10 | 38,2 |
| Third quartile publications | 3 | 8,4 |
| Total publications (including those without IF) | 38 | 223,0 |
